Skip to main content
. 2020 Mar 3;2020(3):CD001838. doi: 10.1002/14651858.CD001838.pub6

Steures 2006a.

Methods Trial design: parallel
 Multicentre: 26 fertility centres in the Netherlands
Participants Couples with unexplained subfertility and an intermediate prognosis of conceiving within the next 12 months (Hunault 30% to 40%)
N randomised: 253; IUI + OH 127; TI (expectant management) + NC 126
Age: IUI + OH 33 years (± 3.4); TI + NC 33 years (± 3.19)
 Duration of subfertility: IUI + OH 2.0 years (± 0.5);TI + NC 1.91 years (± 0.5)
 Basic fertility work‐up done, semen analysis according to WHO 1987, normal postcoital test
 Previous treatment: not stated
Interventions Comparison: IUI + OH versus TI (expectant management) + NC
 Stimulation method: FSH 37 to 150 IU/day or 50 mg to 150 mg CC/day
 Monitoring: USS
 Ovulation: 5000 or 10,000 IU hCG
 Timing: IUI 36 hr to 40 hr after hCG
Cycles were cancelled when > 3 follicles of 16 mm or > 5 follicles of 12 mm were present
Duration of treatment: 6 months
Outcomes Live birth/couple
 PR/couple
 Miscarriage rate
 Multiple pregnancies
Notes ITT analysis: yes
 Author provided additional information
Only couples with an intermediate prognosis of conceiving were included, so this influences the possible treatment effect
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk Computer‐generated sequence in balanced blocks
Allocation concealment (selection bias) Low risk Adequate; via opaque sealed envelopes
Blinding of participants and personnel (performance bias) 
 All outcomes Unclear risk Blinding was not possible because of the nature of the interventions
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk Blinding was not possible because of the nature of the interventions and non‐blinding was not likely to affect the outcomes of interest
Incomplete outcome data (attrition bias) 
 All outcomes Low risk IUI + OH group, 3 participants lost to follow‐up, TI + NC group, 2 lost to follow‐up, 2 still pregnant
Selective reporting (reporting bias) Low risk Live birth and complications reported
Other bias Low risk Nothing detected

ART: assisted reproductive technology
 CC: clomiphene citrate
 DIPI: direct intraperitoneal insemination
 EM: expectant management
 FSH: follicle stimulating hormone
 hCG: human chorionic gonadotropin
 hMG: human menopausal gonadotropin
 hr: hour(s)
 ITT: intention‐to‐treat
 IUI: intra‐uterine insemination
 OH: ovarian hyperstimulation
 PR: pregnancy rate
 USS: ultrasound scan